Prognostic value of 2-[18F]FDG PET-CT in metastatic melanoma patients receiving immunotherapy

Gregor Schweighofer-Zwink,Reyhaneh Manafi-Farid,Peter Kölblinger,Lukas Hehenwarter,Sara Harsini,Christian Pirich,Mohsen Beheshti

European Journal of Radiology（2022）

引用 0|浏览0

暂无评分

摘要

•[18F]FDG PET/CT can be used to predict patients’ outcomes, receiving immunotherapy.•Metabolic parameters are strong predictors of overall survival.•Follow-up PET after 3 months of immunotherapy provided stronger predictive parameters.•Tumor-to-background ratios were more powerful compared to MTV and TLG.

查看译文

关键词

Melanoma,Immunotherapy,Antibody therapy,2-[18F]FDG PET/CT,Prognosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要